| pubmed-article:6955802 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6955802 | lifeskim:mentions | umls-concept:C0033147 | lld:lifeskim |
| pubmed-article:6955802 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:6955802 | lifeskim:mentions | umls-concept:C0042396 | lld:lifeskim |
| pubmed-article:6955802 | lifeskim:mentions | umls-concept:C2917403 | lld:lifeskim |
| pubmed-article:6955802 | lifeskim:mentions | umls-concept:C0069541 | lld:lifeskim |
| pubmed-article:6955802 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6955802 | pubmed:dateCreated | 1982-10-21 | lld:pubmed |
| pubmed-article:6955802 | pubmed:abstractText | 17 (S)methyl-omega-homo trans delta 2 PGE1 (ONO 1206) an analogue of PGE1 was studied on vasopressin-induced ECG changes in four male monkeys and three female baboons. Bolus intravenous doses of vasopressin (0.8 I.U. to 1.0 I.U./kg) produced flattening of the T wave (2 monkeys) elevation of ST segment (1 baboon and 1 monkey) and inversion of T wave (1 baboon). Inverted T waves were also present in one baboon and one monkey prior to any drug administration. In four out of seven animals, boLus intravenous doses (5 to 15 micrograms/kg) of ONO 1206 reversed the ECG changes produced by vasopressin and in one animal ONO 1206 reversed the existing inverted T wave. These findings indicate that vasopressin is a suitable agent for the induction of coronary vasoconstriction in primates and that ONO 1206 is able to reverse this effect. | lld:pubmed |
| pubmed-article:6955802 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6955802 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6955802 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6955802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6955802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6955802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6955802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6955802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6955802 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6955802 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:6955802 | pubmed:issn | 0262-1746 | lld:pubmed |
| pubmed-article:6955802 | pubmed:author | pubmed-author:KarimS MSM | lld:pubmed |
| pubmed-article:6955802 | pubmed:author | pubmed-author:AdaikanP GPG | lld:pubmed |
| pubmed-article:6955802 | pubmed:author | pubmed-author:KottegodaS... | lld:pubmed |
| pubmed-article:6955802 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6955802 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:6955802 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6955802 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6955802 | pubmed:pagination | 343-8 | lld:pubmed |
| pubmed-article:6955802 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:meshHeading | pubmed-meshheading:6955802-... | lld:pubmed |
| pubmed-article:6955802 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6955802 | pubmed:articleTitle | Reversal of vasopressin-induced coronary vasoconstriction by a PGE1 analogue (ONO 1206) in primates. | lld:pubmed |
| pubmed-article:6955802 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6955802 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6955802 | lld:pubmed |
